Viking Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Go back to Viking Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Viking Therapeutics (VKTX) Misses Q3 EPS by 2c

November 8, 2017 4:13 PM EST

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.22), $0.02 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

... More